Pfizer applies to register COVID-19 vaccine in Brazil

Reuters · 02/06/2021 13:04
Pfizer applies to register COVID-19 vaccine in Brazil

- Brazilian health regulator Anvisa said on Saturday that Pfizer Inc PFE.N has applied for full regulatory approval of its COVID-19 vaccine developed with BioNTech Se 22UAy.DE.

This is the second vaccine submitted for registration in Brazil. AstraZeneca Plc AZN.L applied for full regulatory approval on Jan. 29 for the vaccine it developed with Oxford University. It will be made in Brazil in partnership with the federally funded Fiocruz biomedical center.



(Reporting by Anthony Boadle
Editing by Frances Kerry)

((anthony.boadle@tr.com +55 61 98204-1110; https://twitter.com/anthonyboadle ;))